1-3 of 3
Tomasz Sewastianik
Close
Sort by
Journal Articles

Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenström macroglobulinemia

Clinical Trials & Observations
Jorge J. Castillo, Edward N. Libby, Stephen M. Ansell, M. Lia Palomba, Kirsten Meid, Catherine A. Flynn, Carly Leventoff, Christopher B. Hergott, Tomasz Sewastianik, Elizabeth A. Morgan, Ruben Carrasco, Jonathan R. Fromm, Guang Yang, Zachary Hunter, Steven P. Treon
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5089–5092.
https://doi.org/10.1182/bloodadvances.2020003087
Published: 2020
Journal Articles

Human MYD88 L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells

Tomasz Sewastianik, Maria Luisa Guerrera, Keith Adler, Peter S. Dennis, Kyle Wright, Vignesh Shanmugam, Ying Huang, Helen Tanton, Meng Jiang, Amanda Kofides, Maria G. Demos, Audrey Dalgarno, Neil A. Patel, Anwesha Nag, Geraldine S. Pinkus, Guang Yang, Zachary R. Hunter, Petr Jarolim, Nikhil C. Munshi, Steven P. Treon, Ruben D. Carrasco
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3360–3374.
https://doi.org/10.1182/bloodadvances.2019000588
Published: 2019
Includes: Supplemental data
Journal Articles

Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice

Tomasz Sewastianik, Meng Jiang, Kumar Sukhdeo, Sanjay S. Patel, Kathryn Roberts, Yue Kang, Ahmad Alduaij, Peter S. Dennis, Brian Lawney, Ruiyang Liu, Zeyuan Song, Jessie Xiong, Yunyu Zhang, Madeleine E. Lemieux, Geraldine S. Pinkus, Jeremy N. Rich, David M. Weinstock, Charles G. Mullighan, Norman E. Sharpless, Ruben D. Carrasco
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2361–2374.
https://doi.org/10.1182/bloodadvances.2017012211
Published: 2017
Includes: Supplemental data